Suppr超能文献

对乙酰氨基酚引起的中毒性表皮坏死松解症,皮肤脱落几乎达100%:对乙酰氨基酚与严重皮肤不良反应风险相关。

Toxic epidermal necrolysis caused by acetaminophen featuring almost 100% skin detachment: Acetaminophen is associated with a risk of severe cutaneous adverse reactions.

作者信息

Watanabe Hideaki, Kamiyama Taisuke, Sasaki Shun, Kobayashi Kae, Fukuda Kenichiro, Miyake Yasufumi, Aruga Tohru, Sueki Hirohiko

机构信息

Department of Dermatology, Showa University School of Medicine, Tokyo, Japan.

Department of Emergency and Critical Care Medicine, Showa University, Tokyo, Japan.

出版信息

J Dermatol. 2016 Mar;43(3):321-4. doi: 10.1111/1346-8138.13073. Epub 2015 Sep 12.

Abstract

Toxic epidermal necrolysis (TEN) is an adverse reaction that can be induced by various drugs; the associated mortality rate is 20-25%. A previous report showed a weak association between TEN and acetaminophen. Recently, the US Food and Drug Administration declared that acetaminophen is associated with a risk of serious skin reactions, including TEN. Here, we describe the case of a 43-year-old Japanese woman with TEN caused by acetaminophen. She had poorly controlled ulcerative colitis and was treated with high doses of prednisolone, infliximab, acetaminophen and lansoprazole. Nine days after administrating acetaminophen, targetoid erythematous and bullous lesions appeared on the patient's trunk, palms and the soles of her feet. The skin lesions expanded rapidly; within 3 weeks, skin detachment was detected across nearly 100% of the patient's body. However, no mucosal involvement of the eyes, oral cavity or genitalia was found. We performed lymphocyte transformation tests using various drugs; however, a high stimulation index was obtained only with acetaminophen. The patient recovered following treatment with plasmapheresis, i.v. immunoglobulin therapy, topical medication and supportive therapy. Acetaminophen is included in many prescription and over-the-counter products; thus, clinicians should monitor their patients for severe drug reactions, including TEN.

摘要

中毒性表皮坏死松解症(TEN)是一种可由多种药物诱发的不良反应;其相关死亡率为20%至25%。此前有报告显示TEN与对乙酰氨基酚之间存在微弱关联。最近,美国食品药品监督管理局宣布对乙酰氨基酚与包括TEN在内的严重皮肤反应风险相关。在此,我们描述一例由对乙酰氨基酚引起TEN的43岁日本女性病例。她患有控制不佳的溃疡性结肠炎,接受高剂量泼尼松龙、英夫利昔单抗、对乙酰氨基酚和兰索拉唑治疗。服用对乙酰氨基酚九天后,患者躯干、手掌和脚底出现靶样红斑和水疱性皮损。皮肤损害迅速扩大;三周内,几乎患者全身100%出现皮肤剥脱。然而,未发现眼睛、口腔或生殖器的黏膜受累。我们使用多种药物进行淋巴细胞转化试验;然而,仅对乙酰氨基酚获得了高刺激指数。患者经血浆置换、静脉注射免疫球蛋白治疗、局部用药和支持治疗后康复。对乙酰氨基酚包含在许多处方药和非处方药产品中;因此,临床医生应监测患者是否出现包括TEN在内的严重药物反应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验